Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07106151 · ClinicalTrials.gov registry record · NA
Outpatient Recovery From Acute Kidney Injury Requiring Dialysis - 2
A NA study of AKI and AKI - Acute Kidney Injury, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT07106151 is a NA study of AKI and AKI - Acute Kidney Injury that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 40 participants, below the 82-participant average among 4 other AKI trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07106151, a NA study of AKI and AKI - Acute Kidney Injury, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Providing additional information to patients with acute kidney injury who continue dialysis after hospital discharge and to the accepting kidney doctor (nephrologist) who manages their dialysis may be feasible and beneficial. This study will pilot measuring the patient's residual kidney function at the time of discharge and communicating that result to the accepting nephrologist and the patient, along with information on recommended recovery monitoring frequency and criteria for consideration of a twice-weekly hemodialysis schedule.
Conditions Studied
Interventions
- BEHAVIORAL Transmission of additional AKI-D recovery information
- OTHER No additional AKI-D recovery information
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-02-23 |
| Est. Completion | 2028-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07106151
The ClinicalTrials.gov registry entry for NCT07106151 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 82-participant average among 4 other AKI trials with a reported enrollment target (51% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with AKI appearing as the primary indexed condition, and to 2 interventions - of which Transmission of additional AKI-D recovery information is the first listed.
NCT07106151 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT07106151 about?
NCT07106151 is a clinical study titled "Outpatient Recovery From Acute Kidney Injury Requiring Dialysis - 2". Providing additional information to patients with acute kidney injury who continue dialysis after hospital discharge and to the accepting kidney doctor (nephrologist) who manages their dialysis may be feasible and beneficial. This study will pilot measuring the patient's residual kidney function at ...
What is the current status of trial NCT07106151?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2026-02-23. Estimated completion is 2028-01.
What conditions does trial NCT07106151 study?
This clinical trial studies the following conditions: AKI, AKI - Acute Kidney Injury, Dialysis Patients.
What interventions are being tested in trial NCT07106151?
The interventions under investigation include: Transmission of additional AKI-D recovery information (BEHAVIORAL), No additional AKI-D recovery information (OTHER).
Who is sponsoring clinical trial NCT07106151?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07106151 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for AKI
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
NO During CPB in Neonates to Reduce Risk of AKI
RECRUITING · Phase 3
-
Effect of RBT-1 on Preconditioning Response Biomarkers in Subjects Undergoing CABG and/or Cardiac Valve Surgery
COMPLETED · Phase 2
-
Intraoperative Transesophageal Echocardiography Assessment of Portal Vein Flow and Renal Resistive Index As a Predictor of Acute Kidney Injury After Cardiac Surgery: A Prospective Observational Study
COMPLETED
-
Protection From Acute Kidney Injury (AKI) With Basis™ Treatment
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.